Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M304Revenue $M164Net Margin (%)-30.2Altman Z-Score0.1
Enterprise Value $M268EPS $-0.8Operating Margin %-24.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.3Pre-tax Margin (%)-30.3Higher ROA y-yY
Price/Book1.510-y EBITDA Growth Rate %--Quick Ratio2.0Cash flow > EarningsY
Price/Sales1.85-y EBITDA Growth Rate %--Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow12.2y-y EBITDA Growth Rate %--ROA % (ttm)-10.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-20.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M67.3ROIC % (ttm)-20.0Gross Margin Increase y-yN

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 4.52-60%Sold Out0
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 4.52-67%New holding19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-60.7view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-63.1view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-60.42view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-59.96view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-61.2view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-58.72view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-59.24view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-63.84view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-61.69view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-62.33view

Quarterly/Annual Reports about SPPI:

News about SPPI:

Articles On GuruFocus.com
AT&T Will Benefit From DirecTV Acquistion Aug 14 2015 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
Spectrum (SPPI) Initiates Phase III Study on SPI-2012 Feb 01 2016
Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel,... Jan 29 2016
Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel,... Jan 29 2016
Biotechnology Stocks Technical Data -- Regulus Therapeutics, Progenics Pharma, Spectrum Pharma, and... Jan 12 2016
Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada Jan 11 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 11 2016
Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada Jan 11 2016
Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 7,... Jan 07 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Jan 05 2016
Healthcare Sector Equities Under the Scanner -- Xenoport, Tetraphase Pharma, uniQure, and Spectrum... Dec 29 2015
Spectrum Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 22 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of... Dec 18 2015
Pre-market Equity Watch on Biotechnology -- Agenus, Arrowhead Research, Spectrum Pharma, and... Dec 18 2015
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events Dec 16 2015
Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for... Dec 16 2015
Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for... Dec 16 2015
TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers Dec 15 2015
INVESTOR ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Spectrum... Dec 15 2015
Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows... Dec 10 2015
INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and... Dec 09 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK